ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy

By Fahmy I.  

Human Reproduction, Vol. 19, Iss. 7, 2004-07 ,pp. : 1558-1561

Oxford University Press

Access to resources Recommend Favorite

Seminal anti-Mllerian hormone level is a marker of spermatogenic response during long-term gonadotropin therapy in male hypogonadotropic hypogonadism

By Sinisi A.A.   Esposito D.   Maione L.   Quinto M.C.   Visconti D.   De Bellis A.   Bellastella A.   Conzo G.   Bellastella G.  

Human Reproduction, Vol. 23, Iss. 5, 2008-05 ,pp. : 1029-1034

Oxford University Press

Access to resources Recommend Favorite

Male Hypogonadism: An Update on Diagnosis and Treatment

By Darby Emily   Anawalt Bradley D.  

Treatments in Endocrinology, Vol. 4, Iss. 5, 2005-01 ,pp. : 293-309

Adis International

Access to resources Recommend Favorite

The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women

By Westergaard Lars G.   Erb Karin   Laursen Steen   Rasmussen Per E.   Rex Sven  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1209-1213

Oxford University Press

Access to resources Recommend Favorite

Andrology. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men

By Liu Peter Y.  

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1540-1545

Oxford University Press

Access to resources Recommend Favorite